Clinical Trial Update: PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study [Phase 2]

View source ↗

Summary

Filament Health Corp. is conducting a Phase 2 feasibility trial of PEX010 for opioid use disorder; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• PEX010 (PEX010)

Snippet

Sponsor: Filament Health Corp. | Conditions: Opioid Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING